Clinical Trials on Anticoagulants; Increased in Japan

Total 2 results

Takeshi Morimoto

Completed

Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study (ONCO DVT)

Neoplasms | Venous Thrombosis | Anticoagulant

Japan
Takeshi Morimoto
Bayer Yakuhin, Ltd.

Active, not recruiting

Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer (ONCO PE)

Neoplasms | Venous Thrombosis | Anticoagulants

Japan

3

Subscribe